Advanced company searchLink opens in new window

CURVE THERAPEUTICS LIMITED

Company number 11989962

Filter by category

Filter by category


Confirmation statement filters, selecting an input will reload the page.
Confirmation statement filters, selecting an input will reload the page.

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
08 Jun 2026 CH01 Director's details changed for Ms Marie-Claire Peakman on 8 June 2026
08 Jun 2026 CH01 Director's details changed for Mr Shahzad Malik on 8 June 2026
08 Jun 2026 CH01 Director's details changed for Mr Robert Armstrong on 8 June 2026
08 Jun 2026 CS01 Confirmation statement made on 9 May 2026 with updates
05 Jun 2026 SH01 Statement of capital following an allotment of shares on 21 May 2026
  • GBP 3,305.9547
19 Mar 2026 TM01 Termination of appointment of Simon Kerry as a director on 3 March 2026
11 Jun 2025 AD01 Registered office address changed from Delta House Enterprise Road Southampton Science Park SO16 7NS England to Delta House Enterprise Road Southampton Science Park Southampton SO16 7NS on 11 June 2025
15 May 2025 AA Accounts for a small company made up to 31 December 2024
14 May 2025 AD01 Registered office address changed from C/O Advent Life Sciences 27 Fitzroy Square London W1T 6ES England to Delta House Enterprise Road Southampton Science Park SO16 7NS on 14 May 2025
09 May 2025 CS01 Confirmation statement made on 9 May 2025 with updates
10 Dec 2024 MR04 Satisfaction of charge 119899620001 in full
25 Sep 2024 AP01 Appointment of Dr Andreas Hoekema as a director on 1 September 2024
22 May 2024 AA Accounts for a small company made up to 31 December 2023
10 May 2024 CS01 Confirmation statement made on 9 May 2024 with updates
26 Feb 2024 PSC08 Notification of a person with significant control statement
22 Feb 2024 MA Memorandum and Articles of Association
22 Feb 2024 RESOLUTIONS Resolutions
  • RES10 ‐ Resolution of allotment of securities
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES01 ‐ Resolution of adoption of Articles of Association
16 Feb 2024 SH01 Statement of capital following an allotment of shares on 29 January 2024
  • GBP 3,192.2062
16 Feb 2024 PSC07 Cessation of Advent Life Sciences Llp as a person with significant control on 29 January 2024
16 Feb 2024 PSC07 Cessation of Epidarex Capital Iii Uk Lp as a person with significant control on 29 January 2024
16 Feb 2024 AP01 Appointment of Ms Carmine Circelli as a director on 12 January 2024
16 Feb 2024 AP01 Appointment of Mr Robert Armstrong as a director on 12 January 2024
09 Feb 2024 AP01 Appointment of Ms Marie-Claire Peakman as a director on 12 January 2024
07 Feb 2024 TM01 Termination of appointment of Ali Tavassoli as a director on 12 January 2024
07 Feb 2024 TM01 Termination of appointment of Diana Felicity Galpin as a director on 12 January 2024